The role of H4 flagella in Escherichia coli ST131 virulence

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kakkanat, Asha ^a   Totsika, Makrina ^b   Schaale, Kolja ^a   Duell, Benjamin L ^c   Lo, Alvin W ^a   Phan, Minh Duy ^a   Moriel, Danilo G ^a   Beatson, Scott A ^a   Sweet, Matthew J ^a   Ulett, Glen C ^c   Schembri, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BETA LACTAMASE; FIMBRIA PROTEIN; FIMH PROTEIN, E COLI; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; QUINOLONE DERIVATIVE;

BACTERIUM ADHERENCE; BIOSYNTHESIS; CELL MOTION; ESCHERICHIA COLI; FLAGELLUM; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; URINARY TRACT INFECTION;

ADHESINS, ESCHERICHIA COLI; BACTERIAL ADHESION; BETA-LACTAMASES; CELL MOVEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FIMBRIAE PROTEINS; FLAGELLA; FLUOROQUINOLONES; HUMANS; INTERLEUKIN-10; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 84946926615     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16149     Document Type: Article

References (74)

1. Stamm, W. E. & Norrby, S. R. Urinary tract infections: disease panorama and challenges. J Infect Dis 183 Suppl 1, S1-4, doi: 10.1086/318850 (2001).
2. Johnson, J. R. et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 207, 919-928, doi: 10.1093/infdis/jis933 (2013).
3. Dason, S., Dason, J. T. & Kapoor, A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 5, 316-322, doi: 10.5489/cuaj.11214 (2011).
4. Totsika, M. et al. Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 13, 1386-1399 (2012).
5. Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13, 269-284, doi: 10.1038/nrmicro3432 (2015).
6. Laupland, K. B., Ross, T., Pitout, J. D., Church, D. L. & Gregson, D. B. Community-onset urinary tract infections: a populationbased assessment. Infection 35, 150-153, doi: 10.1007/s15010-007-6180-2 (2007).
7. Foxman, B. & Brown, P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17, 227-241 (2003).
8. Riley, L. W. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 20, 380-390, doi: 10.1111/1469-0691.12646 (2014).
9. Nicolas-Chanoine, M. H. et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61, 273-281, doi: 10.1093/jac/dkm464 (2008).
10. Coque, T. M. et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14, 195-200, doi: 10.3201/eid1402.070350 (2008).
11. Lau, S. H. et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62, 1241-1244, doi: 10.1093/jac/dkn380 (2008).
12. Petty, N. K. et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA 111, 5694-5699, doi: 10.1073/pnas.1322678111 (2014).
13. Price, L. B. et al. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 4, e00377-00313, doi: 10.1128/mBio.00377-13 (2013).
14. Totsika, M. et al. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J Infect Dis 208, 921-928, doi: 10.1093/infdis/jit245 (2013).
15. Rogers, B. A., Sidjabat, H. E. & Paterson, D. L. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66, 1-14, doi: 10.1093/jac/dkq415 (2011).
16. Namba, K., Yamashita, I. & Vonderviszt, F. Structure of the core and central channel of bacterial flagella. Nature 342, 648-654, doi: 10.1038/342648a0 (1989).
17. Orskov, F. & Orskov, I. Escherichia coli serotyping and disease in man and animals. Can J Microbiol 38, 699-704 (1992).
18. Mulvey, M. A., Schilling, J. D. & Hultgren, S. J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69, 4572-4579, doi: 10.1128/iai.69.7.4572-4579.2001 (2001).
19. Mobley, H. L. et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58, 1281-1289 (1990).
20. Wright, K. J., Seed, P. C. & Hultgren, S. J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 73, 7657-7668, doi: 10.1128/iai.73.11.7657-7668.2005 (2005).
21. Duan, Q., Zhou, M., Zhu, L. & Zhu, G. Flagella and bacterial pathogenicity. J Basic Microbiol 53, 1-8, doi: 10.1002/jobm.201100335 (2013).
22. Hadjifrangiskou, M. et al. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol 194, 6195-6205, doi: 10.1128/jb.01012-12 (2012).
23. Lane, M. C., Alteri, C. J., Smith, S. N. & Mobley, H. L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci USA 104, 16669-16674, doi: 10.1073/pnas.0607898104 (2007).
24. Lane, M. C. et al. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 73, 7644-7656, doi: 10.1128/iai.73.11.7644-7656.2005 (2005).
25. Pichon, C. et al. Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells. Cell Microbiol 11, 616-628, doi: 10.1111/j.1462-5822.2008.01278.x (2009).
26. Ramos, H. C., Rumbo, M. & Sirard, J. C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 12, 509-517, doi: 10.1016/j.tim.2004.09.002 (2004).
27. Steiner, T. S. How flagellin and toll-like receptor 5 contribute to enteric infection. Infect Immun 75, 545-552, doi: 10.1128/iai.01506-06 (2007).
28. Miao, E. A., Andersen-Nissen, E., Warren, S. E. & Aderem, A. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol 29, 275-288, doi: 10.1007/s00281-007-0078-z (2007).
29. Zhao, Y. & Shao, F. The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus. Immunol Rev 265, 85-102, doi: 10.1111/imr.12293 (2015).
30. Stephenson, H. N. et al. Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: a novel flagellin-host interaction. J Infect Dis 210, 1487-1498, doi: 10.1093/infdis/jiu287 (2014).
31. Wyant, T. L., Tanner, M. K. & Sztein, M. B. Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes. Infect Immun 67, 3619-3624 (1999).
32. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103, doi: 10.1038/35074106 (2001).
33. Duell, B. L., Carey, A. J., Dando, S. J., Schembri, M. A. & Ulett, G. C. Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli. PLoS One 8, e78013, doi: 10.1371/journal.pone.0078013 (2013).
34. Bokil, N. J. et al. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology 216, 1164-1171, doi: 10.1016/j.imbio.2011.05.011 (2011).
35. Mavromatis, C. H. et al. The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions. Cell Microbiol 17, 730-746, doi: 10.1111/cmi.12397 (2015).
36. Totsika, M. et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6, e26578, doi: 10.1371/journal.pone.0026578 (2011).
37. Ren, C. P., Beatson, S. A., Parkhill, J. & Pallen, M. J. The Flag-2 locus, an ancestral gene cluster, is potentially associated with a novel flagellar system from Escherichia coli. J Bacteriol 187, 1430-1440, doi: 10.1128/jb.187.4.1430-1440.2005 (2005).
38. Paul, S. et al. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J Bacteriol 195, 231-242, doi: 10.1128/jb.01524-12 (2013).
39. Duell, B. L. et al. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol 188, 781-792, doi: 10.4049/jimmunol.1101231 (2012).
40. Johnson, J. R. et al. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother 54, 546-550, doi: 10.1128/AAC.01089-09 (2010).
41. Gibreel, T. M. et al. High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol 50, 3202-3207, doi: 10.1128/jcm.01423-12 (2012).
42. Vimont, S. et al. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7, e46547, doi: 10.1371/journal.pone.0046547 (2012).
43. Nicolas-Chanoine, M. H., Bertrand, X. & Madec, J. Y. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27, 543-574, doi: 10.1128/cmr.00125-13 (2014).
44. Banerjee, R. et al. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 34, 361-369, doi: 10.1086/669865 (2013).
45. Buchholz, U. et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 365, 1763-1770, doi: 10.1056/NEJMoa1106482 (2011).
46. Karlyshev, A. V., Linton, D., Gregson, N. A. & Wren, B. W. A novel paralogous gene family involved in phase-variable flagellamediated motility in Campylobacter jejuni. Microbiology 148, 473-480 (2002).
47. Canals, R. et al. Analysis of the lateral flagellar gene system of Aeromonas hydrophila AH-3. J Bacteriol 188, 852-862, doi: 10.1128/jb.188.3.852-862.2006 (2006).
48. Molero, R., Wilhelms, M., Infanzon, B., Tomas, J. M. & Merino, S. Aeromonas hydrophila motY is essential for polar flagellum function, and requires coordinate expression of motX and Pom proteins. Microbiology 157, 2772-2784, doi: 10.1099/mic.0.049544-0 (2011).
49. Koerdt, A., Paulick, A., Mock, M., Jost, K. & Thormann, K. M. MotX and MotY are required for flagellar rotation in Shewanella oneidensis MR-1. J Bacteriol 191, 5085-5093, doi: 10.1128/jb.00206-09 (2009).
50. Old, D. C. & Duguid, J. P. Selective outgrowth of fimbriate bacteria in static liquid medium. J Bacteriol 103, 447-456 (1970).
51. Wyckoff, T. J., Thomas, B., Hassett, D. J. & Wozniak, D. J. Static growth of mucoid Pseudomonas aeruginosa selects for nonmucoid variants that have acquired flagellum-dependent motility. Microbiology 148, 3423-3430 (2002).
52. Hung, C. et al. Escherichia coli biofilms have an organized and complex extracellular matrix structure. MBio 4, e00645-00613, doi: 10.1128/mBio.00645-13 (2013).
53. Haiko, J. & Westerlund-Wikstrom, B. The role of the bacterial flagellum in adhesion and virulence. Biology (Basel) 2, 1242-1267, doi: 10.3390/biology2041242 (2013).
54. Rossez, Y., Wolfson, E. B., Holmes, A., Gally, D. L. & Holden, N. J. Bacterial flagella: twist and stick, or dodge across the kingdoms. PLoS Pathog 11, e1004483, doi: 10.1371/journal.ppat.1004483 (2015).
55. Giron, J. A., Torres, A. G., Freer, E. & Kaper, J. B. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol Microbiol 44, 361-379 (2002).
56. Erdem, A. L., Avelino, F., Xicohtencatl-Cortes, J. & Giron, J. A. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J Bacteriol 189, 7426-7435, doi: 10.1128/jb.00464-07 (2007).
57. Mahajan, A. et al. An investigation of the expression and adhesin function of H7 flagella in the interaction of Escherichia coli O157: H7 with bovine intestinal epithelium. Cell Microbiol 11, 121-137, doi: 10.1111/j.1462-5822.2008.01244.x (2009).
58. Parthasarathy, G., Yao, Y. & Kim, K. S. Flagella promote Escherichia coli K1 association with and invasion of human brain microvascular endothelial cells. Infect Immun 75, 2937-2945, doi: 10.1128/iai.01543-06 (2007).
59. Schreiber, F. et al. The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions. Sci Rep 5, 7947, doi: 10.1038/srep07947 (2015).
60. Chan, C. Y., St John, A. L. & Abraham, S. N. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38, 349-359, doi: 10.1016/j.immuni.2012.10.019 (2013).
61. Snyder, J. A. et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72, 6373-6381, doi: 10.1128/iai.72.11.6373-6381.2004 (2004).
62. Blanc, V. et al. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 69, 1231-1237, doi: 10.1093/jac/dkt519 (2014).
63. Dahbi, G. et al. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum beta-lactamases. Int J Antimicrob Agents 42, 347-351, doi: 10.1016/j.ijantimicag.2013.06.017 (2013).
64. Olesen, B. et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 51, 1779-1785, doi: 10.1128/jcm.00346-13 (2013).
65. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640-6645, doi: 10.1073/pnas.120163297 (2000).
66. Cherepanov, P. P. & Wackernagel, W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158, 9-14 (1995).
67. Tushinski, R. J. et al. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28, 71-81 (1982).
68. Hohenhaus, D. M. et al. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation. Immunobiology 218, 1345-1353, doi: 10.1016/j.imbio.2013.07.001 (2013).
69. Ulett, G. C. & Adderson, E. E. Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis. J Infect Dis 191, 1761-1770, doi: 10.1086/429693 (2005).
70. Valle, J. et al. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol 190, 4147-4161, doi: 10.1128/jb.00122-08 (2008).
71. Ulett, G. C., Webb, R. I. & Schembri, M. A. Antigen-43-mediated autoaggregation impairs motility in Escherichia coli. Microbiology 152, 2101-2110, doi: 10.1099/mic.0.28607-0 (2006).
72. Givskov, M., Eberl, L., Christiansen, G., Benedik, M. J. & Molin, S. Induction of phospholipase- and flagellar synthesis in Serratia liquefaciens is controlled by expression of the flagellar master operon flhD. Mol Microbiol 15, 445-454 (1995).
73. de Lorenzo, V., Eltis, L., Kessler, B. & Timmis, K. N. Analysis of Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene 123, 17-24 (1993).
74. Chaveroche, M. K., Ghigo, J. M. & d'Enfert, C. A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res 28, E97 (2000).